400 results on '"Schlub, Timothy"'
Search Results
2. Predicting vaccine effectiveness for mpox
3. Randomized controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine
4. Landscape of Human Immunodeficiency Virus Neutralization Susceptibilities Across Tissue Reservoirs
5. Clinical and imaging modality factors impacting radiological interpretation of breast screening in young women with neurofibromatosis type 1
6. Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: a systematic review and meta-analysis
7. Monoclonal antibody levels and protection from COVID-19
8. Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis
9. Effect of core versus enhanced implementation strategies on adherence to a clinical pathway for managing anxiety and depression in cancer patients in routine care: a cluster randomised controlled trial
10. The HIV-1 proviral landscape reveals Nef contributes to HIV-1 persistence in effector memory CD4+ T-cells
11. HIV-1 Genomes Are Enriched in Memory CD4+ T-Cells with Short Half-Lives
12. Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection
13. Determinants of passive antibody efficacy in SARS-CoV-2 infection: a systematic review and meta-analysis
14. HIV persists throughout deep tissues with repopulation from multiple anatomical sources
15. High levels of genetically intact HIV in HLA-DR+ memory T cells indicates their value for reservoir studies.
16. Preferences for return of germline genome sequencing results for cancer patients and their genetic relatives in a research setting
17. Psychological impact of comprehensive tumor genomic profiling results for advanced cancer patients
18. Psychological predictors of cancer patients' and their relatives’ attitudes towards the return of genomic sequencing results
19. Cancer patient knowledge about and behavioral intentions after germline genome sequencing
20. Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1.
21. The impact of cutaneous neurofibromas on quality of life and mental health in neurofibromatosis type 1.
22. Exploring Lecturer and Student Perceptions and Use of a Learning Management System in a Postgraduate Public Health Environment
23. Treatment of Multidrug-resistant or Rifampicin-resistant Tuberculosis With an All-oral 9-month Regimen Containing Linezolid or Ethionamide in South Africa: A Retrospective Cohort Study
24. Saffron therapy for the ongoing treatment of age-related macular degeneration
25. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
26. Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants
27. Predicting vaccine effectiveness in Mpox
28. Does functional assessment predict everyday visual functioning? Visual function testing and quality of life in mild/moderate age-related macular degeneration
29. Fate mapping reveals the age structure of the peripheral T cell compartment
30. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19
31. Validation of multiplex PCR sequencing assay of SIV
32. No detectable effect of Wolbachia w Mel on the prevalence and abundance of the RNA virome of Drosophila melanogaster
33. The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory [CD4.sup.+] T cells
34. Saffron therapy for the treatment of mild/moderate age-related macular degeneration: a randomised clinical trial
35. Modeling of EBV Infection and Antibody Responses in Kenyan Infants With Different Levels of Malaria Exposure Shows Maternal Antibody Decay is a Major Determinant of Early EBV Infection
36. Interaction between maternally derived antibodies and heterogeneity in exposure combined to determine time-to-first Plasmodium falciparum infection in Kenyan infants
37. Preferential selection of viral escape mutants by CD8+ T cell 'sieving' of SIV reactivation from latency.
38. Impact of Plasmodium falciparum Coinfection on Longitudinal Epstein-Barr Virus Kinetics in Kenyan Children
39. Understanding surgeon decision making in the use of radiotherapy as neoadjuvant treatment in rectal cancer
40. AFLIBERCEPT FOR PERSISTENT DIABETIC MACULAR EDEMA: Forty-Eight–Week Outcomes
41. Meta-transcriptomics reveals a diverse antibiotic resistance gene pool in avian microbiomes
42. Impact of core versus enhanced implementation strategies on adherence to a clinical pathway for managing anxiety and depression in cancer patients in routine care: A cluster randomised controlled trial
43. Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4
44. Side effects are incompletely reported among systematic reviews in gastroenterology
45. Population heterogeneity in Plasmodium vivax relapse risk
46. Monoclonal antibody levels and protection from COVID-19
47. Characterization of health concerns in people with neurofibromatosis type 1
48. Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?
49. Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema
50. Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.